Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Caribou Biosciences, Inc.
Scientific Title
A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients With Relapsed/Refractory B Cell Non-Hodgkin Lymphoma